Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiquimod (Aldara): modifying the immune response.

Sherrill Jantzi Rudy1

  • 1Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

Dermatology Nursing
|September 21, 2002
PubMed
Summary

Imiquimod 5% cream is an immune response modifier that enhances innate and cell-mediated immunity. This topical treatment, approved for HPV infections, shows potential for various skin conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric dermatology: fungal/yeast infections, viral infections, acne, and hemangiomas.

Dermatology nursing·2008
Same author

Pediatric dermatology: transient conditions, genodermatoses, dermatitis, and bacterial infections.

Dermatology nursing·2007
Same author

Overview of the evaluation and management of acne vulgaris.

Pediatric nursing·2003
Same author

Percutaneous absorption of topically applied medication.

Dermatology nursing·2003

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Imiquimod 5% cream is a novel topical immune response modifier.
  • It activates both innate and cell-mediated immune responses.
  • Current indication is for genital human papillomavirus infections.

Purpose of the Study:

  • To explore the potential of imiquimod 5% cream beyond its current indication.
  • To highlight its immunomodulatory properties for broader dermatological applications.

Main Methods:

  • Review of imiquimod's mechanism of action.
  • Analysis of its effects on innate and cell-mediated immunity.
  • Evaluation of existing and potential therapeutic applications.

Main Results:

  • Imiquimod stimulates key immune pathways.
  • Demonstrates efficacy in treating viral skin infections.
  • Shows promise for neoplastic and immune-mediated skin diseases.

Conclusions:

  • Imiquimod 5% cream possesses broad immunomodulatory capabilities.
  • Its potential extends to treating a range of viral, neoplastic, and immune-mediated skin conditions.
  • Further research is warranted for expanded clinical use.

Related Experiment Videos